| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 278, Issue 37, 35826-35836, September 12, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|| **
From the
Departments of Biochemistry and
¶Pediatrics, and Canadian Institutes of Health
Research Group on Molecular & Cell Biology of Lipids, University of
Alberta, Edmonton, Alberta T6G 2S2, Canada
Received for publication, June 16, 2003 , and in revised form, July 2, 2003.
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
30% of hepatic phosphatidylcholine biosynthesis
(1–4).
The enzymes of the CDP-choline pathway, which are active in all nucleated
cells, catalyze the remaining 70% of PC biosynthesis in the liver
(2–5).
In addition to being a key modulator of PC biosynthesis, the liver is the
site of 85% of all methylation reactions
(6). AdoMet, the primary methyl
group donor, is utilized by at least 39 mammalian methyltransferases,
including DNA, RNA, protein, lipid, and small molecule methyltransferases
(7,
8). Each AdoMet-dependent
transmethylation reaction generates AdoHcy, which in turn is hydrolyzed to
yield adenosine and the non-protein amino acid, homocysteine (Hcy)
(9). Because mild
hyperhomocysteinemia is an independent risk factor for cardiovascular and
atherosclerotic disease, circulating plasma homocysteine levels are of
significant clinical interest
(10).
Previous studies on PEMT focused on the PC biosynthetic function of the enzyme and, in particular, whether PEMT-derived PC was targeted to a specific hepatic fate such as very low density lipoprotein particles or bile (11–14). Recently, however, phenotypic analysis of mice homozygous for a disrupted PEMT allele revealed a novel role for PEMT in the regulation of plasma Hcy levels (15). Although the liver is the site of numerous AdoMet-dependent methylation reactions, each of which contributes to the Hcy pool, genetic ablation of the PEMT gene alone resulted in a 50% decrease in circulating Hcy levels (15). Furthermore, hepatoma cells transfected with a cDNA encoding PEMT secreted more Hcy than mock transfected cells (15). Combined, these results suggest a key yet previously unknown role for PEMT in the regulation of hepatic one-carbon metabolism.
To gain further insight into the PEMT transmethylation reaction and the mechanism by which this enzyme modulates plasma Hcy levels, we sought to identify residues that are required to bind AdoMet/AdoHcy. A plethora of enzymes bind AdoMet and/or AdoHcy, including the AdoMet-dependent methyltransferases, AdoMet synthetase, AdoMet decarboxylase, and AdoHcy hydrolase (16). Comparative amino acid sequence analysis previously identified several conserved motifs that bind the AdoMet/AdoHcy moieties, but a small number of methyltransferases including the eukaryotic PEMT family of enzymes do not contain any of these motifs (16–18).
Using bioinformatic analysis, two putative AdoMet/AdoHcy-binding motifs were identified that are conserved among the eukaryotic PEMT proteins. Here, we describe the biochemical evaluation of the motifs in the human PEMT enzyme. Understanding the nature of the interaction between AdoMet/AdoHcy and PEMT will promote resolution of the mechanism by which the enzyme modulates plasma Hcy levels and facilitate the design of agents for therapeutic intervention in cases of hyperhomocysteinemia.
|
EXPERIMENTAL PROCEDURES |
|---|
|
TOPABSTRACTINTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
Bioinformatic Analysis—The PROWL ProteinInfo sequence analysis program (prowl.rockefeller.edu) was used to screen for putative AdoMet-binding motifs in the predicted human PEMT primary structure (accession number, NP_009100 [GenBank] ). The ALIGN program (based on the ClustalW algorithm) at the San Diego Supercomputer Biology Workbench (workbench.sdsc.edu) was utilized to analyze the conservation of motifs between orthologous eukaryotic PEMT enzymes (19).
Recombinant Plasmid Construction—Mutant PEMT derivatives for analysis of putative AdoMet-binding residues/motifs were generated by the "splice by overlap extension" PCR mutagenesis method, using the wild type hPEMT-pCI plasmid as a template for all reactions (20, 21). This plasmid consists of the human PEMT open reading frame cloned 5' to 3' into the XhoI and XbaI sites, respectively, of the pCI mammalian expression vector polylinker (Promega) (21). Transcription is under the control of a cytomegalovirus promoter. Full-length mutant PCR products were blunt end-ligated to SmaI-cut pBluescript II (KS) (Stratagene) and recloned into the pCI expression vector using XhoI and XbaI restriction sites. All of the constructs were sequenced to confirm fidelity of amplification and orientation of the insert at the Molecular Biology Services Unit of the University of Alberta. Plasmids encoding conservative GXG motif mutants were generated as follows. To mutagenize the glycine residue at the first position in the GXG tripeptide motif to an alanine residue and generate the plasmid, hP-G98A, PCR A was performed with oligonucleotide 1 (5'-CTCGAGATGACCCGGCTGCTGGGCTAC-3') and oligonucleotide 2 (5'-CAGGAGCGCGAGGCCCAGGCTG-3'), PCR B was performed with the mutant oligonucleotide 3 (5'-AGCCTGGGCCTCGCGCTCCTGGCACTGGGCGTCGT-3') and oligonucleotide 4 (5'-TCTAGATCAGCTCCTCTTGTGGGAC-3'), and PCR C, to generate the full-length mutant product, was performed with oligonucleotides 1 and 4, using amplicons from PCR A and B as templates. Each of the other mutant plasmids was produced by the same protocol but using a different mutant oligonucleotide (oligonucleotide 3) for the construction of each PEMT derivative. To mutagenize the glycine residue at the second position in the GXG tripeptide motif to an alanine residue and generate the plasmid, hP-G100A, oligonucleotide 3 was 5'-AGCCTGGGCCTCGCGCTCCTGGGACTGGCCGTCGT-3'. To mutagenize both glycine residues in the GXG tripeptide motif to alanine residues and generate the plasmid, hP-GAGA, 5'-AGCCTGGGCCTCGCGCTCCTGGCACTGGCCGTCGT-3' was the mutant oligonucleotide. For construction of the single and combinatorial non-conservative GXG mutant plasmids, the mutant oligonucleotides were as follows: hP-G98E, 5'-AGCCTGGGCCTCGCGCTCCTGGAACTGGGCGTCGT-3'; hP-G100D, 5'-AGCCTGGGCCTCGCGCTCCTGGGACTGGACGTCGT-3'; and hP-GEGD, 5'-AGCCTGGGCCTCGCGCTCCTGGAACTGGACGTCGT-3'. Plasmids encoding the di-glutamate motif mutants E180D and E181D were generated as follows. To mutate the glutamate at position 180 to an aspartate residue and generate the plasmid, hP-E180D, PCR A was performed with oligonucleotide 1 (as above) and oligonucleotide 5 (5'-ATAGGAGAGCCATTATGTAGGTG-3'), PCR B was performed with the mutant oligonucleotide 6 (5'-CTACATAATGGCTCTCCTATACGACGAGCCCTTCACCGCTGAGATC-3') and 4 (as above), and PCR C, to generate the full-length mutant product, was performed with oligonucleotides 1 and 4, using amplicons from PCR A and B as templates. To mutate the glutamate at position 181 to an aspartate residue and generate the plasmid, hP-E181D, a similar protocol was followed except the mutant oligonucleotide was 5'-CTACATAATGGCTCTCCTATACGAAGATCCCTTCACCGCTGAGATC-3'.
Cell Culture and Transfections—Cos-7 cells, obtained from the American Type Culture Collection repository, were maintained in Dulbecco's modified Eagle's medium, 10% fetal bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin sulfate at 37 °C with 5% CO2. Transfection of various plasmids encoding PEMT and mutant PEMT derivatives was performed using the FuGENE reagent as described previously (22).
PEMT Activity Assays and Immunoblots—PEMT activity assays were performed as described previously using phosphatidylmonomethylethanolamine (PMME) as the methyl acceptor and S-adenosyl-L-[methyl-3H]methionine as the methyl group donor (23). Immunoblots of the recombinant PEMT protein and mutant derivatives were performed as described previously using an anti-PEMT peptide antibody at the indicated concentrations (22).
S-Adenosylmethionine Binding Assays—Binding assays were performed on microsomes prepared from transiently transfected Cos-7 cells. The microsomes were prepared as described previously except the resultant microsomal pellet was resuspended in 75 µl of Buffer X (50 mM Tris-HCl, pH 9.5, 5 mM dithiothreitol) (22). Binding assays were carried out according to a modified version of the method of Zhu et al. (24). Briefly, microsomal protein (50 µg) was incubated with 10 µCi of S-adenosyl-L-[methyl-3H]methionine (15 Ci/mmol) in Buffer X for 10 min at 37 °C (total assay volume, 30 µl). The binding assay mixture was passed over a HAWP 02500 filter (Millipore) on a filtration funnel, and unbound S-adenosyl-L-[methyl-3H]methionine was removed by washing with 100 ml of Buffer X. The filters were dried, and bound S-adenosyl-L-[methyl-3H]methionine was quantitated by liquid scintillation spectrometry. Similar assays were performed in the absence of microsomal protein to account for nonspecific binding of S-adenosyl-L-[methyl- 3H]methionine to the filter. Binding assays on microsomes from mock transfected cells quantitated AdoMet bound by microsomal components other than PEMT. Binding activities of microsomes from cells expressing mutant PEMT proteins were expressed relative to the binding activity of microsomes from cells expressing the unmodified enzyme.
Microtitre S-Adenosylmethionine Binding Assays—Binding assays were adapted for high throughput analysis as follows. Briefly, microsomal protein (30 µg), prepared as above, was incubated with 3 µCi of radiolabeled AdoMet and the indicated concentrations of unlabeled AdoMet for 10 min at 37 °C in a round-bottomed microtitre plate. 200 µl of Buffer X was added to each sample, and the resultant mixture was transferred to a 96-well filtration plate (MHABN4510, Millipore) and centrifuged immediately at 1500 x g for 5 min. Microtitre plates were placed on an aspiration apparatus, and each well was washed 15 times with 200 µl of Buffer X. Microtitre filters were air-dried, 50 µl of Microscint PS (Packard Biosciences) was added to each well, and bound S-adenosyl-L-[methyl-3H]methionine was quantitated by liquid scintillation spectrometry in a microbeta scintillation counter (model 1450, Wallac Trilux). Control binding assays were performed as described above for nonmicrotitre S-adenosylmethionine binding assays.
Statistical Analyses—The data are expressed as the means ± S.E. The Student-Newman-Keuls method was utilized to perform an analysis of variance to determine statistical significance (p < 0.05).
Kinetic Analyses—Kinetic data were analyzed according to the Michaelis-Menten equation and with nonlinear regression algorithms using the Curvefit kinetic analysis program (Graphpad.com).
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
|
|
Conservative Mutagenesis of the GXG Motif—To probe the role
of the conserved glycine residues in PEMT-mediated binding of the AdoMet
moiety, each glycine residue of the GXG motif was individually
mutated to an alanine residue (encoded by the mutant PEMT plasmids, hP-G98A
and hP-G100A). To evaluate the effect of conservative mutagenesis of each
glycine residue on PEMT activity, Cos-7 cells were transfected with plasmids
encoding wild type PEMT or the mutant PEMT derivatives or mock transfected
with empty vector, and cell homogenate protein was assayed for PEMT activity.
Mutagenesis of Gly98 to an alanine residue decreased PEMT activity
by 25%, whereas similar mutagenesis of Gly100 completely
abolished enzymatic activity in the recombinant PEMT derivatives
(Fig. 3A). Immunoblots
with an anti-PEMT peptide antibody demonstrated similar levels of abundance of
the recombinant proteins (Fig.
3B). Enzymatic assays of homogenates performed in the
presence of various concentrations of substrate revealed that conservative
mutagenesis of Gly98 results in a slightly elevated
Km with respect to the methyl donor, AdoMet, but not with
respect to the methyl acceptor, PMME (Fig.
3, C and D). Thus, mutagenesis of
Gly98 would appear to have perturbed a facet of the
transmethylation reaction pertaining to the AdoMet moiety. The hP-G100A mutant
was inactive at all concentrations of PMME and AdoMet evaluated (data not
shown).
|
Conservative Mutagenesis of 100G Abolishes AdoMet Binding Activity—To determine whether the changes in PEMT activity were specifically due to decreased AdoMet binding activity, we transfected Cos-7 cells with the wild type or mutant PEMT plasmids or mock transfected with empty vector. The microsomes were prepared for AdoMet binding assays. The microsomal fraction was utilized for AdoMet binding assays because we have previously demonstrated that PEMT activity is enriched in the microsomal subcompartment (22).
Microsomes from cells expressing the mutant hp-G98A protein displayed a
reduction of 20% in AdoMet binding activity compared with the unmodified
enzyme (Fig. 4A). In
contrast, conservative mutagenesis of Gly100 completely abolished
the AdoMet binding activity of the mutant enzyme. To determine whether the
altered enzymatic activity of the mutant recombinant PEMT proteins was a
consequence of direct changes in AdoMet binding activity, binding assays were
performed with various concentrations of AdoMet. Mutagenesis of
Gly98 to an alanine results in a PEMT derivative with an elevated
KD with respect to AdoMet, relative to values for the
unmodified enzyme (Fig.
4B). Thus, a specific role for the GXG motif in
binding of the AdoMet moiety is supported. Increasing concentrations of AdoMet
did not result in detectable AdoMet binding activity for the Gly100
mutant (data not shown), suggesting that the integrity of this residue is
essential to the AdoMet binding function of PEMT.
|
Nonconservative and Combinatorial Mutations of the GXG Motif—To further investigate the role of the glycine residues in the putative AdoMet-binding motif, we performed nonconservative mutagenesis of each glycine residue to glutamate or aspartate residues to yield the mutant plasmids hP-G98E and hP-G100D, respectively. Additionally, combinatorial mutant plasmids were generated in which both glycine residues were mutated to alanine residues (hP-GAGA) or to glutamate and aspartate residues (hP-GEGD). To assess the PEMT activity of the nonconservative and combinatorial mutants, Cos-7 cells were transiently transfected with wild type or mutant plasmids or mock transfected with empty vector. The cellular homogenates were assayed for PEMT activity.
The cells expressing the nonconservative mutant PEMT derivatives (hP-G98E and hP-G100D) were completely inactive as compared with mock transfected cells (Fig. 5A). In the case of hP-G98E, this was in contrast to the conservative G98A mutation, which only caused a decrease of 20% in PEMT activity (Fig. 3A). Cells expressing the combinatorial mutant PEMT derivatives were similarly devoid of PEMT activity (Fig. 5A). Immunoblots with an anti-PEMT peptide antibody confirmed the expression of each PEMT derivative (Fig. 5B). Assays performed in the presence of various concentrations of PMME or AdoMet did not demonstrate enzymatic activity in any of the nonconservative or combinatorial GXG mutants (Fig. 5, C and D).
|
Nonconservative Mutagenesis of Gly98 Reduces AdoMet Binding Activity—In the next series of experiments, we resolved the issue of whether the reduction in PEMT activity of the nonconservative hP-G98E mutant was due to a specific decrease in the AdoMet binding activity of the recombinant mutant protein. Cos-7 cells were transfected, and microsomal AdoMet binding assays were performed as described.
Although the cells expressing the mutant hP-G98E protein did not display
any significant PEMT activity (Fig.
5A), the mutant protein still retained 55% of AdoMet
binding activity as compared with the unmodified enzyme
(Fig. 6A). Binding
assays performed in the presence of various concentrations of AdoMet revealed
that the mutant hP-G98E protein displays an increased KD
with respect to AdoMet, relative to values for the unmodified enzyme
(Fig. 6B). Combined,
these results suggest that although the mutant protein is partially capable of
binding AdoMet, the bound AdoMet moiety is not available for PEMT-catalyzed
transmethylation (i.e. the mutant PEMT enzyme is unable to transfer
the methyl group from the bound AdoMet moiety). This may arise because AdoMet
is bound in such a conformation that the methyl group is not accessible to the
transmethylation machinery. Furthermore, because mutagenesis of
Gly98 to the small amino acid, alanine, had only minimal effects on
both PEMT activity and binding activity (Figs.
3A and
4A), but mutation to
the larger and charged glutamate residue caused a significant decrease in
binding activity (Fig. 6, A and
B), Gly98 may serve to structurally position
Gly100 or other residues for optimal binding activity rather than
actually binding to AdoMet itself.
|
As expected, the hP-G100D mutant protein and the combinatorial mutant PEMT derivative, hP-GEGD did not bind AdoMet, whereas the mutant PEMT protein, hP-GAGA, retained only fractional activity (Fig. 6A). Assays performed in the presence of various concentrations of AdoMet did not enhance binding (data not shown).
Identification of a Second Putative AdoMet-binding Motif—A
number of AdoMet-dependent methyltransferases do not contain the classical
AdoMet-binding motifs (16,
17,
26). Analysis of enzymes that
lack the three classical AdoMet-binding motifs (including the yeast
PEM2-encoded PEMT ortholog) identified a novel tripartite motif
(Fig. 7A)
(18), referred to in
abbreviated form as the "RHPXY-hyd-EE" motif. This motif
consists of two regions of homology (Region A and Region B) separated by a
hydrophobic region of 30 residues
(18). To determine whether the
tripartite motif is conserved among the higher eukaryotic PEMT enzymes, we
performed feature analysis of the aligned amino acid sequences. Although the
greater part of Regions A and B do not exist in human PEMT, two specific
portions of the motifs, which flank the hydrophobic region, are conserved,
i.e. PXY-hydrophobic region-EE, where X represents
any amino acid (Fig. 7).
|
Recently, we demonstrated that PEMT is a quatrotopic ER membrane protein with a topographical orientation that localizes both termini external to the ER subcompartment (22). Such a topographical orientation would localize the PXY motif to the ER lumen and the di-glutamate motif to the external surface of the ER membrane. Because AdoMet is most concentrated in the cytosolic compartment, we hypothesize that the di-glutamate motif is more likely to function in an AdoMet binding capacity in human PEMT (29).
Mutagenesis of the Di-glutamate Motif Decreases PEMT Activity—To examine the role of the conserved di-glutamate motif in binding to AdoMet, we mutated each glutamate residue to an aspartate residue to generate the mutant PEMT plasmids hP-E180D and hP-E181D. To evaluate the conservative glutamate mutants, we assayed PEMT activity in homogenates from cells that express the recombinant PEMT derivatives. Mutagenesis of Glu180 to an aspartate residue completely abolished PEMT activity, whereas similar mutagenesis of Glu181 resulted in a 70% decrease in PEMT activity (Fig. 8A). Immunoblots with an anti-PEMT peptide antibody demonstrated similar levels of abundance of the recombinant proteins (Fig. 8B). Provision of various concentrations of PMME or AdoMet did not suffice to restore the enzymatic activity to wild type levels (Fig. 8, C and D). However, assays performed in the presence of various concentrations of AdoMet revealed an elevated Km with respect to AdoMet in the case of the hP-E181D mutant (Fig. 8D). Thus, a role for the di-glutamate motif in an AdoMet-specific aspect of the transmethylation reaction is suggested.
|
Mutagenesis of the Di-glutamate Motif Diminishes AdoMet Binding Activity—To elucidate whether the changes in PEMT activity could be attributed to a reduction in AdoMet binding activity, we performed microsomal AdoMet binding assays on transfected cells. Mutation of Glu180 to an aspartate residue abolished the AdoMet binding capacity of the recombinant mutant enzyme (Fig. 9A). Similar mutagenesis of Glu181 yielded a protein that exhibited a 55% decrement in AdoMet binding activity (Fig. 9A). Binding assays of the hP-E181D PEMT derivative did not detect binding activity at any AdoMet concentration evaluated (data not shown). Thus, the integrity of residue Glu180 is essential to the AdoMet binding activity of PEMT. Mutagenesis of Glu181 results in a PEMT derivative with significantly reduced AdoMet binding ability (KD, 666.7 pmol) relative to the wild type enzyme (KD, 303.1 pmol) (Fig. 9B). Because the changes in binding activity and enzymatic activity of the hP-E181D mutant are proportionally similar (Figs. 8A and 9A), and the replacement of Glu181 with an aspartate residue yields a protein with severely reduced AdoMet binding ability, it appears that the altered PEMT activity of the di-glutamate mutants was a consequence of specific changes in the AdoMet binding activity. Thus, a functional role for the di-glutamate motif in the AdoMet binding activity of the human PEMT enzyme is supported.
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
To gain insight into the PEMT transmethylation reaction and, thereby, the mechanism by which genetic ablation of PEMT can cause decreased circulating plasma homocysteine levels, we examined the role of specific PEMT amino acid residues in the binding of AdoMet/AdoHcy. We have now identified two distinct motifs that are required for PEMT to bind the methyl donor.
Three AdoMet-binding motifs are conserved in the majority of the AdoMet-dependent methyltransferases, but these motifs are absent from several enzymes including those of the eukaryotic PEMT family and the isoprenylcysteine carboxyl methyltransferase (ICMT) family of enzymes (16, 18). The ICMT enzymes constitute part of a post-translational modification process, in which proteins that terminate in a CAAX motif, such as Ras, undergo isoprenylation, C-terminal proteolytic cleavage and carboxyl methylation (10). Although absent from all eukaryotic PEMT enzymes, the three classical AdoMet-binding motifs are present in the prokaryotic Rhodobater sphaeroides PEMT ortholog, encoded by the pmtA gene (16, 32). However, this enzyme is a soluble cytosolic protein that has little homology with the higher eukaryotic, membrane-bound PEMT orthologs (32, 33).
A partial consensus AdoMet-binding motif (98GXG100) is conserved in the eukaryotic PEMT enzymes, and site-directed mutagenesis of each glycine residue demonstrated their importance in the AdoMet binding activity of PEMT. Whereas an intact Gly100 residue is essential for binding of the AdoMet moiety, Gly98 may serve in a structural capacity, because conservative mutagenesis of the residue was quite well tolerated. Moreover, significant binding activity was retained even when Gly98 was substituted with a glutamate residue. However, because the KD with respect to AdoMet was elevated in the case of each Gly98 mutant, a role for this residue in binding of AdoMet is suggested. Our data do not allow us to exclude the possibility that the glutamate residue is also mediating the binding of AdoMet, especially because we have demonstrated the role of other PEMT glutamate residues in AdoMet binding. However, because an intact Gly100 residue is essential for AdoMet binding function, and the replacement of Gly98 with an alanine residue has a lesser impact on AdoMet binding, insertion of a glutamate residue combined with an intact Gly100 might be expected to result in enhanced AdoMet binding. Because this was not the case, we favor a structural role for Gly98 in the AdoMet binding activity of the human PEMT enzyme.
To further define the AdoMet binding site of human PEMT, we examined a novel, recently proposed, AdoMet-binding motif (RHPXY-hyd-EE) (18). This nonclassical motif was derived following alignment-based analyses of the ICMT family of enzymes, homologs thereof, the yeast PEM2 enzyme, and several sterol reductases (18). By in silico analysis, we determined that the consensus motif is also partially conserved in the rat, mouse, and human PEMT orthologs.
Topographical analysis of Ste14p, a member of the ICMT family of methyltransferases, indicated that the enzyme is oriented in the ER membrane such that the two flanking regions of the motif are colocalized on the external face of the membrane (18). Such an orientation might be possible because the intervening hydrophobic domain is predicted to "double back" within the membrane plane through the use of a helical hairpin (18). The C-terminal transmembrane domain of the yeast PEM2 enzyme is proposed to adopt a similar structural conformation (18).
In contrast, the corresponding transmembrane domain in the human PEMT enzyme is shorter than the minimum length (31 amino acids) necessary for helical hairpin formation, and a topographical model based on four transmembrane domains has been elucidated (22). Such a topographical structure would position the two flanking segments of the motif on opposite sides of the ER membrane. Hence, in this model, the N-terminal portion of the motif (PXY) is lumenally oriented and therefore diametrically opposed to the AdoMet-rich cytosol (22, 29). Although we have not eliminated the possibility that the lumenally oriented PXY motif might still have a role in the AdoMet binding activity of PEMT, our working hypothesis is that the cytosolic-localized di-glutamate motif is the functional AdoMet-binding portion of the RHPXY-hyd-EE motif in the human PEMT enzyme.
Mutagenesis of the di-glutamate motif coupled with AdoMet binding assays
verified the importance of the glutamate pair, with Glu180 in
particular being essential to the AdoMet binding activity of PEMT. However,
Glu181 also has a role in AdoMet binding, because mutagenesis of
the residue results in a significantly elevated KD with
respect to AdoMet. Nucleotide-binding proteins such as p21, contain an
invariant acidic residue and a GXGXXG motif that are
separated by 20 amino acids
(34). Hydrogen bonding between
the acidic residue of such proteins and the 2'-hydroxy group of the
adenosine ribose has been demonstrated
(34). Thus, either or both
glutamate residues in the conserved di-glutamate motif of PEMT may bind the
AdoMet moiety through hydrogen bonding. Mutagenesis of each glutamate residue
to an aspartate residue reduced AdoMet binding activity. Although aspartate
residues may also form hydrogen bonds, the shorter length of the aspartate
side chain may impair the AdoMet binding capacity of the residues in this
region of the human PEMT enzyme.
From the topographical orientation of the PEMT enzyme and the predicted length of the transmembrane domains, we envision a model that would position the conserved GXG and diglutamate motifs toward the cytosolic face of the third and fourth transmembrane helices, respectively (Fig. 10). This would provide optimal access to the AdoMet pool in the cytosol (29). Moreover, because the third and fourth transmembrane helices are adjacent domains, the conserved GXG and di-glutamate motifs may be juxtaposed (Fig. 10). Intriguingly, S-adenosylhomocysteine hydrolase, which hydrolyzes AdoHcy to Hcy and adenosine, is also localized in the cytosol (35). Thus, the combined topographical organization of these disparate elements may provide the basis of a mechanism that links the AdoMet-dependent PEMT reaction to circulating Hcy levels.
|
In summary, we identified two closely oriented amino acids motifs in the human PEMT enzyme that are essential for binding of AdoMet. The resolved AdoMet-binding site of PEMT is unique in that it conforms to neither the classical nor nonclassical binding motifs but rather is a novel combination of both classes. Because PEMT has been shown to modulate circulating plasma Hcy levels, the enzyme represents a novel target for therapeutic intervention in patients with hyperhomocysteinemia. Resolution of key motifs that bind AdoMet will greatly accelerate the design of such therapeutic agents.
|
FOOTNOTES |
|---|
This paper is dedicated to the memory of Eraldo Antonini, eminent
biochemist, who died prematurely 20 years ago, March 19, 1983. 
Supported by a Studentship from the Alberta Heritage Foundation for Medical
Research.
|| Senior Scholar of the Alberta Heritage Foundation for Medical Research.
** Canada Research Chair in Molecular and Cell Biology of Lipids and Heritage Medical Scientist of the Alberta Heritage Foundation for Medical Research. To whom correspondence should be addressed: 320 HMRC Dept. of Biochemistry, University of Alberta, Edmonton, AB T6G 2S2, Canada. Tel.: 780-492-8286; Fax: 780-492-3383; E-mail: Dennis.Vance{at}ualberta.ca.
1 The abbreviations are: PC, phosphatidylcholine; AdoMet,
S-adenosylmethionine; AdoHcy, S-adenosylhomocysteine; Hcy,
homocysteine; ER, endoplasmic reticulum; PMME,
phosphatidylmonomethylethanolamine; PEMT, phosphatidylethanolamine
N-methyltransferase; ICMT, isoprenylcysteine carboxyl
methyltransferase.
|
ACKNOWLEDGMENTS |
|---|
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONEXPERIMENTAL PROCEDURESRESULTSDISCUSSIONREFERENCES |
|---|
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. Li and D. E. Vance Thematic Review Series: Glycerolipids. Phosphatidylcholine and choline homeostasis J. Lipid Res., June 1, 2008; 49(6): 1187 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Vance, Z. Li, and R. L. Jacobs Hepatic Phosphatidylethanolamine N-Methyltransferase, Unexpected Roles in Animal Biochemistry and Physiology J. Biol. Chem., November 16, 2007; 282(46): 33237 - 33241. [Full Text] [PDF]
|
|
|
|
 |
|
 S H. Mudd, J. T Brosnan, M. E Brosnan, R. L Jacobs, S. P Stabler, R. H Allen, D. E Vance, and C. Wagner Methyl balance and transmethylation fluxes in humans Am. J. Clinical Nutrition, January 1, 2007; 85(1): 19 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Shields, S. Lingrell, L. B. Agellon, J. T. Brosnan, and D. E. Vance Localization-independent Regulation of Homocysteine Secretion by Phosphatidylethanolamine N-Methyltransferase J. Biol. Chem., July 22, 2005; 280(29): 27339 - 27344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hofemeister and P. O'Hare Analysis of the Localization and Topology of Nurim, a Polytopic Protein Tightly Associated with the Inner Nuclear Membrane J. Biol. Chem., January 28, 2005; 280(4): 2512 - 2521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
